Cancer Genetics, Inc.

Cancer Genetics, Inc. delivers advanced diagnostic and preclinical research services focused on precision oncology and genomic medicine. Utilizing state-of-the-art molecular pathology, next-generation sequencing, and biomarker discovery platforms, the company provides vital insights into tumor biology to guide targeted drug development and patient stratification strategy.